This article is
- freely available
Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action
Université des Sciences et Technologies de Lille, Unité de Catalyse et Chimie du Solide – UMR CNRS 8181, Ecole Nationale Supérieure de Chimie de Lille, Bâtiment C7, B.P. 90108, 59652 Villeneuve d' Ascq cedex, France
Inserm U547, Institut Pasteur, 1 rue du Pr Calmette, B.P. 245, 59019 Lille Cedex, France
* Author to whom correspondence should be addressed.
Received: 22 October 2008; in revised form: 14 November 2008 / Accepted: 18 November 2008 / Published: 20 November 2008
Abstract: Ferroquine (FQ or SR97193) is a novel antimalarial drug candidate, currently in development at Sanofi-Aventis. In contrast to conventional drugs, FQ is the first organometallic drug: a ferrocenyl group covalently flanked by a 4-aminoquinoline and a basic alkylamine. FQ is able to overcome the CQ resistance problem, an important limit to the control of Plasmodium falciparum, the principal causative agent of malaria. After fifteen years of effort, it is now possible to propose a multifactorial mechanism of action of FQ by its capacity to target lipids, to inhibit the formation of hemozoin and to generate reactive oxygen species.
Keywords: Malaria; Bioorganometallics; Ferroquine; Mechanism of action; Resistance
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Dubar, F.; Khalife, J.; Brocard, J.; Dive, D.; Biot, C. Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action. Molecules 2008, 13, 2900-2907.
Dubar F, Khalife J, Brocard J, Dive D, Biot C. Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action. Molecules. 2008; 13(11):2900-2907.
Dubar, Faustine; Khalife, Jamal; Brocard, Jacques; Dive, Daniel; Biot, Christophe. 2008. "Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action." Molecules 13, no. 11: 2900-2907.